Roche Holding AG Chairman Christoph Franz expects a breakthrough in finding a treatment for Alzheimer’s disease in the coming years, he tells SonntagsZeitung in an interview.
The fact that we can now diagnose the disease will help in the efforts to find a treatment, he told the Swiss newspaper. “With a trial, we therefore finally know whether the test person really has Alzheimer’s or is suffering from another form of dementia.”
Roche has two drugs in the final stage phase of tests for the disease, Franz said, without naming them.
Asked about a possible successor to Vice Chairman Andre Hoffmann, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.